Edward Benz

Edward Benz, Jr. M.D. is President and Chief Executive Officer of Dana-Farber Cancer Institute, CEO of Dana-Farber/Partners Cancer Care as well as Principal Investigator and Director of Dana-Farber/Harvard Cancer Care and a member of the Governing Board of Dana-Farber/Children’s Hospital Cancer Center. An internationally recognized hematologist, Benz received his training at Brigham and Women’s Hospital, the National Institutes of Health, and Harvard Medical School. He is board certified in Internal Medicine and Hematology.

Benz continues to be an active NIH funded investigator. He has authored over 300 peer reviewed articles, reviews, chapters and abstracts. He is a co-editor of Hematology: Principles and Practice and of the Oxford Textbook of Medicine for which he and his colleagues received the Royal Society of Authors Textbook Award. He is an associate editor of the New England Journal of Medicine.

Benz’ accomplishments have been recognized by a number of distinctions, including membership in the Institute of Medicine of the National Academy of Sciences and the American Academy of Arts and Science. He is a past president of the American Society of Hematology, the American Society of Clinical Investigation and the Association of American Cancer Institutes.

Edward Benz is the CEO at Dana-Farber Cancer Institute, based in United States, North America. With a background in Communities, Edward Benz has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.